Nature Communications (Aug 2024)

PARP1-dependent DNA-protein crosslink repair

  • Zita Fábián,
  • Ellen S. Kakulidis,
  • Ivo A. Hendriks,
  • Ulrike Kühbacher,
  • Nicolai B. Larsen,
  • Marta Oliva-Santiago,
  • Junhui Wang,
  • Xueyuan Leng,
  • A. Barbara Dirac-Svejstrup,
  • Jesper Q. Svejstrup,
  • Michael L. Nielsen,
  • Keith Caldecott,
  • Julien P. Duxin

DOI
https://doi.org/10.1038/s41467-024-50912-x
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 18

Abstract

Read online

Abstract DNA-protein crosslinks (DPCs) are toxic lesions that inhibit DNA related processes. Post-translational modifications (PTMs), including SUMOylation and ubiquitylation, play a central role in DPC resolution, but whether other PTMs are also involved remains elusive. Here, we identify a DPC repair pathway orchestrated by poly-ADP-ribosylation (PARylation). Using Xenopus egg extracts, we show that DPCs on single-stranded DNA gaps can be targeted for degradation via a replication-independent mechanism. During this process, DPCs are initially PARylated by PARP1 and subsequently ubiquitylated and degraded by the proteasome. Notably, PARP1-mediated DPC resolution is required for resolving topoisomerase 1-DNA cleavage complexes (TOP1ccs) induced by camptothecin. Using the Flp-nick system, we further reveal that in the absence of PARP1 activity, the TOP1cc-like lesion persists and induces replisome disassembly when encountered by a DNA replication fork. In summary, our work uncovers a PARP1-mediated DPC repair pathway that may underlie the synergistic toxicity between TOP1 poisons and PARP inhibitors.